Poliovirus (Types 1, 3) Antibodies, Neutralization
Use
This sensitive procedure is recommended for vaccine response testing and type-specific serodiagnosis of recent poliovirus infection. It can also serve as an aid for diagnosing immune deficiency disorders.
Special Instructions
Not provided.
Limitations
This assay has not been cleared or approved by the FDA. Its analytical performance characteristics have been determined by Quest Diagnostics, and it is validated under CLIA regulations for clinical purposes. However, its use is specifically advised for serodiagnosis of poliovirus and not for other diagnostic purposes.
New York Approved
Methodology
Culture-based
Biomarkers
Poliovirus Type 1
MicroorganismPoliovirus Type 3
Microorganism
LOINC Codes
- 68320-1 - PV Ab Pnl Titr Ser
- 22446-9 - PV1 Ab Titr Ser
- 22450-1 - PV3 Ab Titr Ser
Result Turnaround Time
1-10 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Preferred: Red top; Acceptable: Serum gel
Collection Instructions
Centrifuge and aliquot 1 mL of serum into a plastic vial. Ship refrigerated.
Causes for Rejection
All specimens will be evaluated at the performing laboratory for test suitability.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 14 days |
| Frozen | 30 days |